Literature DB >> 21640917

Pancreatic resection in a large tertiary care community-based hospital: building a successful pancreatic surgery program.

Ryan Z Swan1, Kwan N Lau, David Sindram, David A Iannitti, John B Martinie.   

Abstract

Pancreatic resection can be performed safely in the community-based hospital setting only when appropriate systems are in place for patient selection and preoperative, operative, and postoperative care. Pancreatic surgery cannot be performed optimally without considerable investment in, and coordination of, multiple departments. Delivery of high-quality pancreatic cancer care demands a rigorous assessment of the hospital structure and the processes through which this care is delivered; however, when a hospital makes the considerable effort to establish the necessary systems required for delivery of quality pancreatic cancer care, the community and hospital will benefit substantially.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21640917     DOI: 10.1016/j.soc.2011.01.004

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  3 in total

1.  Analyzing the Impact of Compliance with National Guidelines for Pancreatic Cancer Care Using the National Cancer Database.

Authors:  Kathryn Jaap; Marcus Fluck; Marie Hunsinger; Jeffrey Wild; Tania Arora; Mohsen Shabahang; Joseph Blansfield
Journal:  J Gastrointest Surg       Date:  2018-03-28       Impact factor: 3.452

2.  Starting a High-Quality Pancreatic Surgery Program at a Community Hospital.

Authors:  Jeffrey M Hardacre; Siavash Raigani; John Dumot
Journal:  J Gastrointest Surg       Date:  2015-09-10       Impact factor: 3.452

3.  Training and practice of the next generation HPB surgeon: analysis of the 2014 AHPBA residents' and fellows' symposium survey.

Authors:  Ramanathan M Seshadri; Noaman Ali; Susanne Warner; Allyson Cochran; Dionisios Vrochides; David Iannitti; D Rohan Jeyarajah
Journal:  HPB (Oxford)       Date:  2015-09-10       Impact factor: 3.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.